Mirtazapine for anxiety in Parkinson's disease
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether mirtazapine, a medication often used for depression and anxiety, can reduce anxiety symptoms in people with Parkinson's disease. It is for patients with mild to moderate Parkinson's who also experience anxiety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with Parkinson's disease
- Your Parkinson's is mild to moderate (stages 1–3 on a common scale)
- You experience anxiety (either self-reported or diagnosed)
- You have not used certain anxiety or depression medications (SSRIs, SNRIs, benzodiazepines, or beta-blockers) in the last 4 weeks
- You do not have a major depressive disorder or other serious health conditions like heart, liver, or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain treatment, can help reduce anxiety in people with Parkinson's disease. You may qualify if you have both Parkinson's and significant anxiety symptoms.
This trial tests a nasal spray called midazolam to quickly reduce anxiety in people receiving palliative care. If you're an adult in the hospital with sudden anxiety, this could help you feel calmer.
This study uses a special PET brain scan tracer to better understand serotonin receptor activity in people with certain neurodegenerative conditions, especially when they develop hallucinations or delusions. The results may help researchers improve how these brain changes are measured and tracked over time.
This Phase 2 study tests whether taking probiotics can improve depression and mood symptoms in people with Parkinson’s disease. It’s meant for those with mild to moderate depression and stable Parkinson’s and mood treatments.
This study tests whether methylphenidate can reduce apathy (lack of motivation) in people with Parkinson’s disease. It may help if apathy has been persistent for weeks and your Parkinson’s medicines have been stable.
This study tests if a medication called pramipexole can help people with anxiety or depression who also find it difficult to connect socially. It looks at whether the drug can improve your motivation for social interactions and help you feel more connected.
Hear when a new Anxiety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.